Mayo Clinic Laboratories > Hematology > Coagulation disorders > Anticoagulant drug monitoring

Anticoagulant drug monitoring

A growing menu of assays

There are an increasing number of direct oral anticoagulants (DOACs) and direct thrombin inhibitors (DTI) available on the market. With increasing clinical utilization, drug-level monitoring needs also have increased. Some DOACs and DTIs require routine monitoring, while others are monitored in more select clinical situations. Our Special Coagulation Laboratory offers clients access to a growing menu of special coagulation drug assays.

Anticoagulant drug monitoring Test menu

Anticoagulant drug monitoring

Key testing


Fill out the form below and one of our specialists will be in touch.

(BETA) Choose a language to view this content in:
About the translation.